Sorafenib tosylate

• Post Date:

  Jan 22,2018

• Expiry Date:

  Jan 22,2019

• Detailed Description:

  Cas No. :475207-59-1 Quantity: 80Kilograms
  Specs:Not less than 98% on dried basis
  Payment Method: Negotiable
  Anticancer medicine used to treat a certain type of liver, kidney or thyroid cancer called:
  Hepatocellular carcinoma (HCC, a type of liver cancer), when it cannot be treated with surgery
  Renal cell carcinoma (RCC, a type of kidney cancer)
  Differentiated thyroid carcinoma (DTC, a type of thyroid cancer) that can no longer be treated with radioactive iodine and is progressing.

• CAS Registry Number:

  475207-59-1

• Synonyms:

  ;SORAFENIB-D3;4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide monomethanesulfonate;N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea Tolsylate;Sorafenib TsOH salt;

• Molecular Formula:

  C₂₁H₁₆ClF₃N₄O₃·C₇H₈SO

• Molecular Weight:

  637.03

• Molecular Structure:

  

• Company:

  Shandong Langnuo Pharmaceutical Co., Ltd.     [ China ]        

• Contact:

  Jacqueline

• Tel:

  +86-531-88116033

• Fax:

  +86-531-88115352

• Email:

  export@bestcomm.cn